Allogene Therapeutics (ALLO) Net Equity Issued and Repurchased (2018 - 2026)
Allogene Therapeutics (ALLO) posted Net Equity Issued and Repurchased of $450,000 for Q1 2026, down 29.5% from $638,000 a year earlier.
Powered by 
Analysis
Allogene Therapeutics (ALLO) Net Equity Issued and Repurchased (2018 - 2026) Analysis & Trends
For FY2025, Allogene Therapeutics' Net Equity Issued and Repurchased came in at $895,000, down 41.7% from FY2024.
- Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -72.8% (FY2020 to FY2025).
- In prior years, Allogene Therapeutics' Net Equity Issued and Repurchased was $1.54 million in FY2024 (-38.5%), $2.5 million in FY2023 (+1.4%), $2.46 million in FY2022 (-70.5%) and $8.35 million in FY2021 (-98.6%).
- Quarterly Net Equity Issued and Repurchased has run from a low of -$1,000 in Q2 2022 to a high of $3.21 million in Q2 2021 over five years.
- The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q3 2022, with growth of 24.1%; the weakest was Q4 2021, with a decline of 99.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Allogene Therapeutics | 322.04 Mn | -820.62 Mn | - | 646,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 646,000.00 |
| Mar 31, 2026 | 454,000.00 |
| Sep 30, 2025 | 257,000.00 |
| Mar 31, 2025 | 638,000.00 |
| Mar 31, 2024 | 1.65 Mn |
| Dec 31, 2023 | 155,000.00 |
| Sep 30, 2023 | 1.09 Mn |
| Jun 30, 2023 | 1.61 Mn |
| Mar 31, 2023 | 1.73 Mn |
| Dec 31, 2022 | 46,000.00 |
| Sep 30, 2022 | 1.07 Mn |
| Jun 30, 2022 | 24,000.00 |
| Mar 31, 2022 | 1.81 Mn |
| Dec 31, 2021 | 322,000.00 |
| Sep 30, 2021 | 2.38 Mn |
| Jun 30, 2021 | 3.21 Mn |
| Mar 31, 2021 | 6.04 Mn |
| Dec 31, 2020 | 597.35 Mn |
| Sep 30, 2020 | 3.82 Mn |
| Jun 30, 2020 | 4.48 Mn |
API Access
Allogene Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ALLO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ALLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ALLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();